These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 18805458

  • 1. gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.
    Sims NA.
    Mol Cell Endocrinol; 2009 Oct 30; 310(1-2):30-9. PubMed ID: 18805458
    [Abstract] [Full Text] [Related]

  • 2. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation.
    Johnson RW, Brennan HJ, Vrahnas C, Poulton IJ, McGregor NE, Standal T, Walker EC, Koh TT, Nguyen H, Walsh NC, Forwood MR, Martin TJ, Sims NA.
    J Bone Miner Res; 2014 Jun 30; 29(6):1492-505. PubMed ID: 24339143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.
    Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, Baumann H, Judd LM, Giraud AS, Boussioutas A, Zhu HJ, Ernst M.
    Nat Med; 2005 Aug 30; 11(8):845-52. PubMed ID: 16041381
    [Abstract] [Full Text] [Related]

  • 6. Osteoclast-osteoblast communication.
    Matsuo K, Irie N.
    Arch Biochem Biophys; 2008 May 15; 473(2):201-9. PubMed ID: 18406338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Boning up on ephrin signaling.
    Mundy GR, Elefteriou F.
    Cell; 2006 Aug 11; 126(3):441-3. PubMed ID: 16901775
    [Abstract] [Full Text] [Related]

  • 11. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D, Cornish J.
    Bone; 2008 Nov 11; 43(5):813-8. PubMed ID: 18687416
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Leukemia inhibitory factor: a paracrine mediator of bone metabolism.
    Sims NA, Johnson RW.
    Growth Factors; 2012 Apr 11; 30(2):76-87. PubMed ID: 22304408
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
    Axmann R, Böhm C, Krönke G, Zwerina J, Smolen J, Schett G.
    Arthritis Rheum; 2009 Sep 11; 60(9):2747-56. PubMed ID: 19714627
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor family receptors regulating bone turnover: new observations in osteoblastic and osteoclastic cell lines.
    Robinson LJ, Borysenko CW, Blair HC.
    Ann N Y Acad Sci; 2007 Nov 11; 1116():432-43. PubMed ID: 17646260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.